Blog articles
World-first gene therapy trial for Hunter syndrome opens
We explore a new treatment that aims to cross the blood-brain barrier for the first time in Hunter syndrome
Casgevy – how it works
In this week’s article, we revisit Casgevy and explore its utility and application in healthcare
Casgevy – the first CRISPR therapy
The UK has approved a new type of gene therapy for the blood disorders sickle cell disease and beta-thalassaemia, a world-first using CRISPR technology
Pharmacogenomics: The future of preventing adverse drug reactions
In the second part of our pharmacogenomics blog series, we look at how new research could lead to a more effective application of drugs
Test trialled to improve treatment for bowel cancer patients
Post-operative cancer patients may avoid side effects from unnecessary chemotherapy thanks to a genomic test
A ground-breaking new gene therapy has saved the life of its very first NHS patient
A baby girl is showing no further signs of the fatal genetic disorder metachromatic leukodystrophy after treatment with an exciting new gene therapy
Cancer vaccines: Three things you need to know
We shine a spotlight on RNA-based immunotherapies, which are fast becoming a major healthcare focus in the UK
NHS patients to get 'early access' to new RNA cancer vaccines
NHS cancer patients will be able to access emerging RNA-based immunotherapies thanks to a newly announced partnership between BioNTech and the government
Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia
Looking back: Genomics in 2022 (part one)
In the first of our two-part round-up of 2022, we look back at some of this year's most exciting clinical developments in genomics
Events
NHS Genomics Healthcare Summit
The 2024 NHS Genomics Healthcare Summit is taking place on Tuesday 12 December in London.
LinkAGE Webinar 2: CRISPR
Welcome to the second of our new series of expert webinars. In this second webinar Dr James Patterson will discuss CRISPR.